# Cathflo Activase Pediatric Study

> **NCT00307580** · PHASE4 · COMPLETED · sponsor: **Genentech, Inc.** · enrollment: 300 (—)

## Conditions studied

- Dysfunctional Central Venous Access Devices (CVADS)

## Interventions

- **DRUG:** Cathflo Activase (Alteplase)

## Key facts

- **NCT ID:** NCT00307580
- **Lead sponsor:** Genentech, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-04
- **Primary completion:** —
- **Final completion:** 2003-05
- **Target enrollment:** 300 (—)
- **Last updated:** 2014-04-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00307580

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00307580, "Cathflo Activase Pediatric Study". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00307580. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*